Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-10 Sale |
2022-03-14 4:56 pm |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
12,823 | $15.55 | $199,335 | 201,883 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 4:18 pm |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
1,388 | $12.66 | $17,568 | 172,359 (Direct) |
View |
| 2021-06-02 Sale |
2021-06-02 9:43 pm |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
15,037 | $21.64 | $325,383 | 169,872 (Direct) |
View |
| 2021-04-22 Sale |
2021-04-26 9:45 pm |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
87,339 | $26.45 | $2,310,106 | 151,720 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-01 Option Award |
2022-03-03 6:08 pm |
N/A 2032-02-29 |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
199,500 | $0 | 481,451 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 6:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
42,347 | $0 | 481,451 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 4:46 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
3,875 | $0 | 173,747 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-02 9:43 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
33,189 | $0 | 169,872 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 8:36 pm |
N/A 2031-02-28 |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
149,200 | $0 | 464,651 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 8:36 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
34,047 | $0 | 464,651 (Direct) |
View |
| 2021-03-01 Tax Withholding |
2021-03-03 8:36 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
7,333 | $24.06 | 464,651 (Direct) |
View |
| 2021-03-02 Tax Withholding |
2021-03-03 8:36 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
2,844 | $23.25 | 464,651 (Direct) |
View |
| 2021-02-01 Tax Withholding |
2021-02-03 5:29 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
1,308 | $21.35 | 219,064 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 5:29 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
3,875 | $0 | 219,064 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-17 5:07 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
1,300 | $0 | 212,622 (Direct) |
View |
| 2020-12-15 Tax Withholding |
2020-12-17 5:07 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
370 | $4.59 | 212,622 (Direct) |
View |
| 2020-06-01 Tax Withholding |
2020-06-03 4:45 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
9,451 | $1.32 | 244,881 (Direct) |
View |
| 2020-06-01 Exercise |
2020-06-03 4:45 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
33,188 | $0 | 244,881 (Direct) |
View |